POPULATION BASED INCIDENCE OF ESSENTIAL THROMBOCYTHEMIA: AN ALBANIAN STUDY (2007-2021)

EHA Library, Adela Perolla, 387338

NON-THROMBOTIC INCREASED PORTAL VENOUS PRESSURE IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: IS IT JUST A HYPOTHESIS?

EHA Library, Istemi Serin, 387339

ATYPICAL CHRONIC MYELOID LEUKEMIA. CLINICAL AND MOLECULAR FEATURES. A SINGLE CENTER EXPERIENCE.

EHA Library, Javier Alberto Rojas Martínez, 387340

ACQUIRED VON WILLEBRAND DISEASE (AVWD) DIAGNOSTIC PROFILE IN MYELOPROLIFERATIVE NEOPLASIA (MN) PATIENTS IN WESTERN-ESTONIA

EHA Library, Ines Vaide, 387341

TREATMENT OUTCOME OF CHRONIC MYELOMONOCYTIC LEUKEMIA; A SINGLE CENTRE EXPERIENCE FROM PAKISTAN

EHA Library, Nida Anwar, 387342

THE VASCULAR RISK OF ESSENTIAL THROMBOCYTHEMIA AND RELIABILITY OF THROMBOTIC RISK ASSESSMENT SCORES

EHA Library, Arij Cheffai, 387343

ACUTE LYMPHOBLASTIC LEUKEMIA SECONDARY TO ESSENTIAL THROMBOCYTHEMIA: SYSTEMATIC REVIEW AND META-ANALYSIS OF CASE REPORTS

EHA Library, Mihnea-Alexandru Găman, 387344

ROSAI-DORFMAN DISEASE -A SINGLE CENTRE EXPERIENCE OF A RARE HISTIOCYTIC DISORDER

EHA Library, Sanjay Tewari, 387345

FEATURES OF POLYCYTHEMIA VERA WITH THE JAK 2 EXON 12 MUTATION.

EHA Library, Irina Soubortseva, 387346

POLYCYTHEMIA VERA (PV) AND SECONDARY POLYCYTHEMIA (SP): ARE METABOLIC DIFFERENCES JUST THEORIES?

EHA Library, Istemi Serin, 387347

BURDEN OF SYMPTOMS AND SYMPTOM EXPERIENCE OF FILIPINO MYELOPROLIFERATIVE NEOPLASM PATIENTS: A QUALITATIVE PHENOMENOLOGICAL STUDY

EHA Library, Flordeluna Mesina, 387349

BONE MARROW NECROSIS: RARE PRESENTATION OF CHRONIC MYELOID NEOPLASMS SYSTEMIC REVIEW AND CASE REPORT

EHA Library, Verna Cheung, 387350

ATYPICAL CHRONIC MYELOID LEUKEMIA (ACML) AND AUTOIMMUNE DISEASE: REPORT OF TWO CASES.

EHA Library, Caterina Tatarelli, 387351

THE IMPACT OF JAK2V617F MUTATION POSITIVITY IN ESSENTIAL THROMBOCYTHEMIA:ABOUT 74 CASES.

EHA Library, Arij Cheffai, 387352

SOMETIMES IT'S ZEBRAS: SUCCESSFUL TREATMENT OF ERYTHROPOIETIC PROTOPORPHYRIA POST PRIMARY MYELOFIBROSIS WITH GIVOSIRAN - A CASE REPORT

EHA Library, Alina Catana, 387353

A PATIENT WITH SEVERE APLASTIC ANEMIA UNDERWENT ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION. EVIDENCE-BASED NURSING CARE OF PATIENTS COMPLICATED WITH ORAL AND LABIAL TISSUE ULCERATION

EHA Library, Li Wang, 387354

HYPEREOSINOPHILIC SYNDROMES:   CARDIAC EMERGENCY IN THE ELDERLY

EHA Library, ahlam gougas, 387355

TREATMENT OUTCOME AND PROGNOSTIC FACTORS IN CHILDREN AND ADOLESCENTS WITH RELAPSED AND REFRACTORY CLASSIC HODGKIN LYMPHOMA

EHA Library, Nesreen Ali, 387356

ASSESSMENT OF CHEMOTHERAPY-INDUCED TOXICITY IN CHILDREN WITH HODGKIN LYMPHOMA RECEIVING THE EURONET PROTOCOL

EHA Library, Nesreen Ali, 387357

EPIDEMIOLOGY AND OUTCOMES OF HODGKIN LYMPHOMA IN URUGUAY. A NATIONAL REGISTRY

EHA Library, Carolina Oliver, 387358

OUTCOME AND PROGNOSTIC FACTORS OF PEDIATRIC PATIENTS WITH HODGKIN LYMPHOMA: A SINGLE-CENTER EXPERIENCE

EHA Library, Nesreen Ali, 387359

PHASE 1 FIRST IN HUMAN STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF GRC54276, A NOVEL HPK1 THRONINE-KINASE INHIBITOR, IN ADVANCED SOLID TUMOURS AND LYMPHOMAS.

EHA Library, Harsha Doddihal, 387360

THE NEW PD-1 INHIBITOR PROLGOLIMAB IN THE TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN'S LYMPHOMA

EHA Library, Anastasia SEMENOVA, 387361

FIVE-YEAR SINGLE-CENTER EXPERIENCE IN THE TREATMENT OF ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA WITH ABVD

EHA Library, Vojin Vukovic, 387362

DECREASE IN NEUTROPHIL-LYMPHOCYTE RATIO IMPACTS OVERALL SURVIVAL OF ADULT PATIENTS WITH HODGKIN LYMPHOMA AFTER ANTI-PD1 TREATMENT

EHA Library, Christos Varelas, 387363

PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKINN LYMPHOMA

EHA Library, kmira zahra, 387364

TOXICITY PROFILE OF SALVAGE CHEMOTHERAPY REGIMENS IN PATIENTS WITH RELAPSED / REFRACTORY HODGKIN LYMPHOMA.

EHA Library, kmira zahra, 387365

CLINICAL FEATURES, TREATMENT PATTERNS, AND OUTCOMES AMONG 120 PATIENTS WITH MALT LYMPHOMA IN LATIN AMERICA: A STUDY FROM THE GRUPO DE ESTUDIO LATINOAMERICANO DE LINFOPROLIFERATIVOS (GELL)

EHA Library, Alana von Glasenapp, 387366

RISK FACTORS FOR DISEASE PROGRESSION OF MYCOSIS FUNGOIDES AND SÉZARY SYNDROME IN EAST ASIAN POPULATION

EHA Library, Huai-Chueh Gem Wu, 387367

TRIAL IN PROGRESS: PHASE 3 TRIAL OF ODRONEXTAMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA (OLYMPIA-5)

EHA Library, Umberto Vitolo, 387368

TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-1)

EHA Library, Stefano Luminari, 387369

PAX5 ABERRANT EXPRESSION INCORPORATED IN MIPI-SP RISK SCORING SYSTEM EXHIBITS ADDITIVE VALUE IN MANTLE CELL LYMPHOMA

EHA Library, Xin Zhang, 387370

PI3KΔ INHIBITOR LINPERLISIB FOR ELDERLY PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: SUBGROUP ANALYSIS OF A PHASE 2 TRIAL

EHA Library, Xiuhua Sun, 387371

PROGNOSTIC VALUE OF INTERIM POSITRON EMISSION TOMOGRAPHY IN HIGH-TUMOR-BURDEN FOLLICULAR LYMPHOMA

EHA Library, Marta Mora Argumánez, 387372

ANALYSIS OF CLINICAL AND LABORATORY PARAMETERS IN PATIENTS WITH PRIMARY ORBITAL AND ADNEXAL MUCOSSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA- A TWENTY YEARS SINGLE CENTRE EXPERIENCE

EHA Library, Mihailo Smiljanic, 387373

PI3KΔ INHIBITOR LINPERLISIB FOR PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: SUBGROUP ANALYSIS OF A PHASE 2 TRIAL

EHA Library, Lihua Qiu, 387374

EFFICACY OF OBINUTUZUMAB - BASED REGIMENS IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: A RETROSPECTIVE OBSERVATIONAL SINGLE-CENTER STUDY

EHA Library, Nevenka Ridova, 387375

REAL-WORLD OUTCOME OF FOLLICULAR LYMPHOMA IN TAIWAN: A MULTICENTER REGISTRY STUDY

EHA Library, Bor-Sheng Ko, 387376

TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHEMOTHERAPY VERSUS RITUXIMAB PLUS CHEMOTHERAPY IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA-2)

EHA Library, Silvana Novelli, 387377

MAHOGANY: A PHASE 3 TRIAL OF ZANUBRUTINIB PLUS ANTI-CD20 ANTIBODIES VS LENALIDOMIDE PLUS RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR OR MARGINAL ZONE LYMPHOMA

EHA Library, Antonio Salar Silvestre, 387378

PROGNOSTIC SIGNIFICANCE OF SERUM MONOCLONAL PROTEINS BASED ON IMMUNOFIXATION ELECTROPHORESIS IN B CELL NON-HODGKIN LYMPHOMA

EHA Library, Yuyang Gao, 387379

ACQUIRED ANGIOEDEMA ASSOCIATED WITH LYMPHOPROLIFERATIVE DISORDERS: A CASE SERIES

EHA Library, Jun Yen Ng, 387380

TRIAL IN PROGRESS: ODRONEXTAMAB, A CD20×CD3 BISPECIFIC ANTIBODY, FOR THE TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (MZL) – A COHORT FROM THE ELM-2 STUDY

EHA Library, Seok-Goo Cho, 387381

MULTISYSTEM ERDHEIM CHESTER NEOPLASM WITH BRAFV660E MUTATION, PROMINENT EMPERIPOLESIS, HEMOPHAGOCYTOSIS AND FULMINANT COURSE

EHA Library, Dina Soliman, 387382

TRIAL IN PROGRESS: FOLLICULAR LYMPHOMA OUTCOMES IN RELAPSED/REFRACTORY PATIENTS TREATED WITH SYSTEMIC THERAPY IN A REAL-WORLD ASSESSMENT (FLORA)

EHA Library, Gandhi Laurent Damaj, 387383

MEK-KINASE INHIBITOR (TRAMETINIB) AS A TREATMENT OPTION FOR HAIRY CELL LEUKEMIA

EHA Library, Lyubov Al-Radi, 387384

IN THE ERA OF IMMUNOPHENOTYPING AND MOLECULAR DIAGNOSTICS DOES MORPHOLOGY PLAY AN ESSENTIAL ROLE IN DIFFERENTIATING HAIRY CELL LEUKEMIA FROM ITS MIMICS?

EHA Library, Priyavadhana Balasubramanian, 387385

EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC ASPECT OF INDOLENT LYMPHOMAS IN TUNISIA

EHA Library, ons charef, 387386

DIVERSITY OF IGG4-RELATED DISEASE : A CASE SERIES OF FOUR PATIENTS

EHA Library, Hind Hanani, 387387

EVALUATION OF THE THERAPEUTIC RESULTS OF LYMPHOBLASTIC LYMPHOMA TREATED ACCORDING TO THE EORTC 58951 PROTOCOL IN CHILDREN ADOLESCENTS AND YOUNG ADULTS

EHA Library, Hana BEN HAMMAMIA, 387388

INCIDENCE OF NEWLY DIAGNOSED AGGRESSIVE NON-HODGKIN'S LYMPHOMA BEFORE AND DURING THE COVID-19 PANDEMIC IN ISRAEL - A SINGLE CENTER RETROSPECTIVE STUDY

EHA Library, Yotam Bronstein, 387390

PRELIMINARY DATA FROM A FIRST-IN HUMAN PHASE II STUDY OF SEQUENTIAL USE OF SELINEXOR AND CD19 CHIMERIC ANTIGEN RECEPTOR MODIFIED T-CELL THERAPY (CART19) IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Caixia Li, 387391

IMPACT OF RESOURCE AVAILABILITY ON OUTCOMES OF DIFFUSE LARGE B-CELL LYMPHOMA IN PAKISTAN: A DEVELOPING COUNTRY EXPERIENCE

EHA Library, Raheel Iftikhar, 387392

EFFICACY OF SPLENECTOMY IN SPLENIC MARGINAL ZONE LYMPHOMA

EHA Library, Yuriy Yevstakhevych, 387393

DEVELOPMENT OF CARDIOTOXICITY NEGATIVELY IMPACTS IN OVERALL SURVIVAL IN PATIENTS WITH LYMPHOMA TREATED WITH FIRST-LINE ANTHRACYCLINES

EHA Library, Alberto López García, 387394

REAL WORLD STUDY OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE ELDERLY: FOURTEEN YEARS OF ONE CENTER'S EXPERIENCE

EHA Library, Victoria Ramos De Ascanio, 387395

DOSE-ADJUSTED EDOCH AS FIRST-LINE THERAPY IMPROVED PROGNOSIS OF ADULT T-CELL LEUKEMIA/LYMPHOMA: A 11-YEAR MULTICENTER RETROSPECTIVE STUDY IN CHINA

EHA Library, Jianda Hu, 387396

TITLE OF MANUSCRIPT: ESTABLISHING A TRANSNATIONAL HAEMATO-ONCOLOGY CANCER MULTIDISCIPLINARY TEAM DURING THE COVID-19 PANDEMIC IN A RESOURCE LIMITED SETTING

EHA Library, Mohammad Aminul Islam, 387397

ROBUST BRUTON’S TYROSINE KINASE (BTK) DEGRADATION WITH NX-5948, AN ORAL BTK DEGRADER, IN A FIRST-IN-HUMAN PHASE 1A TRIAL IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY B CELL MALIGNANCIES

EHA Library, Kim Linton, 387398

PHASE II STUDY OF BORTEZOMIB, CYTARABINE, AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA

EHA Library, Junghoon Shin, 387399

CHRONIC HEPATITIS B VIRAL ACTIVITY IS AN INDEPENDENT PROGNOSTIC FACTOR OF LYMPHOMA

EHA Library, Ho Sup Lee, 387400

UPDATE ON TRIAL IN PROGRESS: A PHASE 1B STUDY OF ELA026 IN PATIENTS WITH SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (SHLH)

EHA Library, Gary Patou, 387401

IMPACT OF INITIAL CHEMOTHERAPY CYCLES AND CLINICAL CHARACTERISTICS ON OUTCOMES FOR HIV-ASSOCIATED DIFFUSE LARGE B CELL LYMPHOMA PATIENTS: THE CENTRAL AND WESTERN CHINA AIDS LYMPHOMA LEAGUE STUDY

EHA Library, Chaoyu Wang, 387402

OPTIMAL DOSE INTENSITY OF R-CHOP FOR PATIENTS WITH DLBCL AGED 80 YEARS OR OLDER: IS THE R-MINICHOP A GOLD STANDARD?

EHA Library, Hironao Nukariya, 387403

A TRNA-DERIVED SMALL RNAS EXPRESSION SIGNATURE AS A PREDICTIVE AND PROGNOSTIC BIOMARKER IN DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Jun Rao, 387404

REAL-WORLD TREATMENT PATTERNS AND ADVERSE EVENTS AMONG PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA: A RETROSPECTIVE DATABASE STUDY

EHA Library, Charles Dharmani, 387405

REAL-WORLD FIRST-LINE TREATMENT AND OUTCOMES AMONG PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH STANDARD OF CARE

EHA Library, Jiali Yan, 387407

PHARMACOKINETICS, EFFICACY AND SAFETY OF SUBCUTANEOUS VERSUS INTRAVENOUS RITUXIMAB COMBINED WITH CHOP IN CHINESE PATIENTS WITH UNTREATED CD20-POSITIVE DIFFUSE LARGE B CELL LYMPHOMA: A RANDOMIZED TRIAL

EHA Library, Huiqiang Huang, 387408

NIVOLUMAB-BASED THERAPY OF RELAPSED OR REFRACTORY PRIMARY LARGE B-CELL LYMPHOMA OF IMMUNE-PRIVILEGED SITES AND DLBCL WITH SECONDARY CNS INVOLVEMENT

EHA Library, Andrey Gavrilenko, 387409

OUTCOMES OF 22 PATIENTS WITH RELAPSED OR REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: SINGLE INSTITUTE EXPERIENCE

EHA Library, Gayane Tumyan, 387410

CHIDAMIDE WITH AZACITIDINE AND CHOP TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED PERIPHERAL T-CELL LYMPHOMA:INTERIM ANALYSIS OF A PROSPECTIVE,SINGLE CENTER,SINGLE-ARM, PHASE 2 TRIAL

EHA Library, Chunyan Xiao, 387411

EFFICACY EVALUATION AND SAFETY ANALYSIS OF ZANUBRUTINI B COMBINED WITH CHEMOTHERAPY FOR 17 CASES OF RELAPSED REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, qingfeng Chen, 387412

REACTIVATION OF HEPATITIS B VIRUS FOLLOWING RITUXIMAB IN B LYMPHOID HEMOPATHIES

EHA Library, MILED Wafa, 387413

THE PROGNOSTIC SIGNIFICANCE OF APOPTOSIS-INDUCING FACTOR IN DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Elena Vaneeva, 387414

CYTOPENIAS AND BLOOD TRANSFUSION SUPPORT AFTER CAR-T THERAPY

EHA Library, Marcos Rivada, 387415

PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A RETROSPECTIVE STUDY OF THE ZR OR ZRM REGIMEN (ZANUBRUTINIB, RITUXIMAB, METHOTREXATE)

EHA Library, YUE TENG, 387416

SAFETY AND EFFICACY OF AUTOLOGOUS HSCT IN NINE PATIENTS WITH AIDS-RELATED NON-HODGKIN LYMPHOMA

EHA Library, Yao Liu, 387417

POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE AND RITUXIMAB THERAPY IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A SINGLE-INSTITUTION EXPERIENCE FOCUSING ON DETAILED ASSESSMENT OF TOXICITIES

EHA Library, Mitsuhito Hirano, 387418

ZUMA-23: A GLOBAL, PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD OF CARE AS FIRST-LINE THERAPY IN PATIENTS WITH HIGH-RISK LARGE B-CELL LYMPHOMA

EHA Library, Jason WESTIN, 387419

FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONG THE ELDERLY: A TUNISIAN MULTICENTER EXPERIENCE.

EHA Library, kmira zahra, 387420

THE EFFECT OF PRE-TREATMENT SERUM KINDLIN-3 ON HODGKIN AND NON-HODGKIN LYMPHOMAS: A SINGLE CENTER EXPERIENCE

EHA Library, Melike KESKIN, 387421

MULTIPLE PRIMARY TUMORS IN PATIENTS WITH NON-HODGKIN’S LYMPHOMA: A RETROSPECTIVE SINGLE-CENTER STUDY

EHA Library, Lusine SAHAKYAN, 387422

R-ESHAP VS R-ICE AS RESCUE TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA. A SINGLE-CENTEREXPERIENCE.

EHA Library, Belén Pérez-Pinilla, 387423

USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY.

EHA Library, Celia Martinez, 387424

VALIDATION OF THE TRAIL SCORE TO PREDICT TOXICITY IN PATIENTS WITH DLBCL RECEIVING R-CHOP-LIKE THERAPY

EHA Library, Juan Carlos Caballero, 387425

OUTCOMES OF ANTI-CANCER THERAPY IN PATIENTS WITH PROGRESSIVE REFRACTORY/RELAPSED B-CELL LYMPHOMA DURING SEVERE CORONAVIRUS DISEASE 2019 (COVID-19): A REAL-WORLD STUDY FROM CHINA

EHA Library, Guoai Su, 387426

IS THERE ANY VALUE OF GERIATRIC INDICES IN DIFFUSE LARGE B CELL LYMPHOMA OF THE ELDERLY?

EHA Library, Vibor Milunovic, 387427

TRIAL IN PROGRESS: ATHENA-1 – A PHASE 1 STUDY TO ASSESS SAFETY AND TOLERABILITY OF REGN5837 IN COMBINATION WITH ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Pim G. N. J. Mutsaers, 387428

ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA (EATL): MULTICENTRIC REVIEW OF CLINICAL FEATURES AND TREATMENT: ON BEHALF OF GELTAMO (GRUPO ESPAÑOL DE LINFOMAS Y TRASPLANTES DE MÉDULA ÓSEA)

EHA Library, Maria Stefania Infante, 387429

PERIPHERAL T CELL LYMPHOMAS TREATED WITH SYSTEMIC CHEMOTHERAPY, CLINIC CHARACTERISTICS AND RESULTS AFTER TREATMENT: REAL LIFE STUDY IN A TERTIARY CARE HOSPITAL IN SPAIN

EHA Library, Daniel Garcia, 387430

AN ONGOING FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-5948, AN ORAL BRUTON’S TYROSINE KINASE (BTK) DEGRADER, IN PATIENTS WITH RELAPSED/REFRACTORY B CELL MALIGNANCIES

EHA Library, Kim Linton, 387431

CLINICAL CHARACTERISTICS AND OUTCOMES OF  HIV-ASSOCIATED AGGRESSIVE B-CELL NHL IN CHINA

EHA Library, Chaoyu Wang, 387432

CAR-T CELL THERAPY IS A EXCELLENT STRATEGY FOR R/R B-NHL

EHA Library, Kai Hu, 387433

CENTRAL NERVOUS SYSTEM (CNS) RELAPSE IN DIFFUSE LARGE B-CELL LYMPHOMA: CNS-SAMATYA RISK MODEL

EHA Library, Istemi Serin, 387434

TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHOP (O-CHOP) VERSUS R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (OLYMPIA-3)

EHA Library, Benoit Tessoulin, 387435

TREATMENT PATTERN AND OUTCOME IN SYSTEMIC T AND NK CELL LYMPHOMA: AN ASIAN SINGLE CENTER EXPERIENCE

EHA Library, Meng-Ta Sung, 387436

SHORT-TERM EFFICACY AND SAFETY OF ZANUBRUTINIB COMBINED WITH POMALIDOMIDE IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Zenghua Lin, 387437

BONE MARROW INVOLVEMENT IN KOREAN PATIENTS WITH LYMPHOMAS: A 21-YEAR LARGE SINGLE-CENTER STUDY

EHA Library, Min-Sun Kim, 387438

CLINICAL OUTCOMES OF RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: THE ROLE OF AUTOLOGOUS STEM-CELL TRANSPLANTATION IN AN INTEND TO TREAT POPULATION

EHA Library, Isabel Mesquita, 387439

HEMOGLOBIN AND FERRITIN LEVELS ADJUST DIFFERENTLY TO MODERATE AND HIGH ALTITUDE IN DIFFERENT WORLD REGIONS: EVIDENCE FOR A VERY PRECISE OXYGEN SENSING SYSTEM

EHA Library, Max Gassmann, 387987